[go: up one dir, main page]

AR057581A1 - Comprimido de disgregacion rapida intraoral - Google Patents

Comprimido de disgregacion rapida intraoral

Info

Publication number
AR057581A1
AR057581A1 ARP060104991A ARP060104991A AR057581A1 AR 057581 A1 AR057581 A1 AR 057581A1 AR P060104991 A ARP060104991 A AR P060104991A AR P060104991 A ARP060104991 A AR P060104991A AR 057581 A1 AR057581 A1 AR 057581A1
Authority
AR
Argentina
Prior art keywords
disgregation
intraoral rapid
compressed
intraoral
disintegrant
Prior art date
Application number
ARP060104991A
Other languages
English (en)
Original Assignee
Teijin Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Pharma Ltd filed Critical Teijin Pharma Ltd
Publication of AR057581A1 publication Critical patent/AR057581A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente proporciona un comprimido de disgregacion rápida intraoral que se puede formar utilizando un aparato ordinario, que posee una dureza sin ningun problema práctico y que se desintegra rápidamente con una buena sensacion en la cavidad oral. El comprimido de disgregacion rápida intraoral producido mediante por compresion de un gránulo recubierto con un desintegrante, en donde el gránulo contiene también un desintegrante dentro del mismo e hidrocloruro de ambroxol como fármaco dentro y/o fuera del mismo.
ARP060104991A 2005-11-14 2006-11-14 Comprimido de disgregacion rapida intraoral AR057581A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005328722 2005-11-14

Publications (1)

Publication Number Publication Date
AR057581A1 true AR057581A1 (es) 2007-12-05

Family

ID=38023405

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060104991A AR057581A1 (es) 2005-11-14 2006-11-14 Comprimido de disgregacion rapida intraoral

Country Status (12)

Country Link
US (2) US10300021B2 (es)
EP (2) EP1957051B1 (es)
JP (2) JP4934144B2 (es)
KR (1) KR101298379B1 (es)
CN (2) CN103637996A (es)
AR (1) AR057581A1 (es)
AU (1) AU2006312566B2 (es)
CA (1) CA2629487C (es)
ES (1) ES2702757T3 (es)
PE (1) PE20070698A1 (es)
TW (1) TWI478732B (es)
WO (2) WO2007055428A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070698A1 (es) * 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
RU2478375C2 (ru) * 2007-03-13 2013-04-10 ДАЙНИППОН СУМИТОМО ФАРМА Ко., ЛТД. Распадающаяся во рту таблетка
GB2453770A (en) 2007-10-19 2009-04-22 Reckitt Benckiser Healthcare Oral composition comprising a cooling agent
JP5835875B2 (ja) * 2009-06-29 2015-12-24 富士化学工業株式会社 口腔内速崩壊錠の製造方法
UY33455A (es) * 2010-06-16 2012-01-31 Teijin Pharma Ltd Tableta con núcleo recubierto de liberación controlada
KR101828630B1 (ko) * 2010-07-09 2018-02-12 데이진 화-마 가부시키가이샤 구강 내 붕괴 정제
NZ605562A (en) * 2010-07-09 2013-11-29 Teijin Pharma Ltd Deuterated benzylbenzene derivatives and methods of use
CN103429223A (zh) * 2011-01-17 2013-12-04 武田药品工业株式会社 口腔分散片
WO2013001441A1 (en) * 2011-06-29 2013-01-03 Ranbaxy Laboratories Limited Dry formulations of febuxostat
JP6823913B2 (ja) * 2014-06-18 2021-02-03 大正製薬株式会社 固形製剤
JP6073843B2 (ja) * 2014-09-10 2017-02-01 佐藤製薬株式会社 硬度及び崩壊性に優れた口腔内崩壊錠の製造方法及び該製造方法により製造される口腔内崩壊錠
EP3206671B1 (en) 2014-10-16 2024-06-12 Cargill, Incorporated Process for preparing a directly compressible erythritol and uses thereof
WO2017217494A1 (ja) * 2016-06-16 2017-12-21 東和薬品株式会社 口腔内崩壊錠
WO2018021265A1 (ja) * 2016-07-27 2018-02-01 沢井製薬株式会社 口腔内崩壊錠添加用組成物
JP6201017B2 (ja) * 2016-08-04 2017-09-20 佐藤製薬株式会社 硬度及び崩壊性に優れた口腔内崩壊錠の製造方法及び該製造方法により製造される口腔内崩壊錠
JP6651638B2 (ja) * 2016-09-06 2020-02-19 沢井製薬株式会社 口腔内崩壊錠添加用組成物
WO2021099935A1 (en) * 2019-11-18 2021-05-27 Zycie Technolegal Llp Pharmaceutical formulations for managing uric acid content in human body
JP7486258B2 (ja) * 2019-12-26 2024-05-17 物産フードサイエンス株式会社 口腔内崩壊錠用顆粒、その製造方法および口腔内崩壊錠
JP7195660B1 (ja) 2021-09-09 2022-12-26 壽製薬株式会社 口腔内崩壊錠
US20230420715A1 (en) 2021-12-09 2023-12-28 Bloom Energy Corporation Fuel cell system and method of operating thereof at near one hundred percent fuel utilization

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US112196A (en) * 1871-02-28 Improvement in horse-collars
US215500A (en) * 1879-05-20 Improvement in distance-instruments
US134199A (en) * 1872-12-24 Improvement in car-couplings
US98227A (en) * 1869-12-28 Improved railway-car
US49315A (en) * 1865-08-08 Improvement in photographic cameras
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
DE69331839T2 (de) 1992-01-29 2002-12-12 Takeda Chemical Industries, Ltd. Schnellösliche Tablette und ihre Herstellung
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
EP1380308B1 (en) * 1996-07-12 2008-07-09 Daiichi Pharmaceutical Co., Ltd. Quickly disintegrable compression-molded materials and process for producing the same
AR016827A1 (es) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
ID24475A (id) 1997-11-18 2000-07-20 Teijin Limeted Cs Turunan-turunan amina siklik dan penggunaannya sebagai obat
PL340658A1 (en) 1997-11-20 2001-02-12 Teijin Ltd Derivatives of biphenylamidine
ATE282962T1 (de) * 1998-07-24 2004-12-15 Haas Franz Waffel & Keksanlagen Industrie Gmbh Verwendung von erythrit und/oder xylit in backmassen oder teigen für dauerbackwaren aus mehlen und/oder stärken als teilweiser oder vollständiger zuckerersatz
ATE481090T1 (de) 1998-07-28 2010-10-15 Takeda Pharmaceutical Leicht zerfallende feste zubereitung
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
JP4059671B2 (ja) 2000-01-17 2008-03-12 帝人株式会社 ベンズイミダゾール誘導体
WO2002002083A1 (en) 2000-06-30 2002-01-10 Yamanouchi Pharmaceutical Co., Ltd. Tablet rapidly disintegrating in mouth and process for producing the same
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
JP4358117B2 (ja) 2001-03-06 2009-11-04 協和発酵キリン株式会社 口腔内速崩壊錠
US20040122106A1 (en) * 2001-03-06 2004-06-24 Motohiro Ohta Tablets quickly disintegrating in oral cavity
FR2823668B1 (fr) * 2001-04-20 2004-02-27 Ethypharm Lab Prod Ethiques Comprimes effervescents orodispersibles
WO2004064810A1 (ja) * 2003-01-21 2004-08-05 Nippon Shinyaku Co., Ltd. 口腔内速崩性錠剤
SI21403A (sl) 2003-02-27 2004-08-31 LEK farmacevtska dru�ba d.d. Farmacevtska oblika z alendronsko kislino, njenimi solmi ali estri ter postopek za njeno pripravo
RU2375048C2 (ru) * 2003-07-17 2009-12-10 Д-Р Редди'С Лабораторис Инк. Фармацевтическая композиция с набухающим покрытием
CA2540040C (en) 2003-10-07 2012-09-11 Andrx Pharmaceuticals Llc Rapidly disintegrating formulation
JP4592272B2 (ja) 2003-10-08 2010-12-01 シャープ株式会社 給紙カセットおよび給紙装置
US9884014B2 (en) * 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
JP5123517B2 (ja) 2005-11-14 2013-01-23 帝人ファーマ株式会社 アンブロキソール口腔内速崩性錠剤
PE20070698A1 (es) 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
WO2008122993A1 (en) 2007-04-09 2008-10-16 Panacea Biotec Limited Controlled release formulation of coated microparticles

Also Published As

Publication number Publication date
CN103637996A (zh) 2014-03-19
JP4934144B2 (ja) 2012-05-16
US20100009004A1 (en) 2010-01-14
CN101309672B (zh) 2015-07-29
CN101309672A (zh) 2008-11-19
JP2009515871A (ja) 2009-04-16
KR20080073335A (ko) 2008-08-08
WO2007055427A1 (en) 2007-05-18
KR101298379B1 (ko) 2013-08-20
JP2011225624A (ja) 2011-11-10
EP1957051A1 (en) 2008-08-20
PE20070698A1 (es) 2007-08-17
EP1957051A4 (en) 2011-07-06
AU2006312566A1 (en) 2007-05-18
WO2007055428A1 (en) 2007-05-18
CA2629487C (en) 2014-11-18
EP1951203A4 (en) 2011-07-06
TW200738282A (en) 2007-10-16
US9511029B2 (en) 2016-12-06
US10300021B2 (en) 2019-05-28
US20090117182A1 (en) 2009-05-07
ES2702757T3 (es) 2019-03-05
EP1957051B1 (en) 2018-11-14
EP1951203A1 (en) 2008-08-06
TWI478732B (zh) 2015-04-01
AU2006312566B2 (en) 2012-04-12
CA2629487A1 (en) 2007-05-18

Similar Documents

Publication Publication Date Title
AR057581A1 (es) Comprimido de disgregacion rapida intraoral
UY31205A1 (es) Composiciones de tabletas de desintegracion oral de lamotrigina
AR109796A2 (es) Formas de dosificación farmacéutica
CR10349A (es) Tabletas de paracetamol de liberacion rapida
AU2010308458A8 (en) Orally transformable tablets
CR9353A (es) Una formulacion solida de dosificacion farmaceutica
AR060409A1 (es) Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja y la terapia combinada relacionada a estos agonistas
CA117315S (en) Container
MX2010009222A (es) Soluciones farmaceuticas, proceso de preparacion y usos terapeuticos.
EA201200550A1 (ru) Фармацевтические композиции, включающие bi-1356 и метформин
AR065235A1 (es) Tapones puntuales y metodos de administracion de agentes terapeuticos
CL2007003429A1 (es) Tableta bi-capa que comprende una primera capa con al menos un estrogeno y una segunda capa con uno o mas agentes terapeuticos seleccionados entre un modulador selectivo del receptor de estrogeno y un agente progestacional; proceso de produccion, uti
UY30961A1 (es) Comprimido famacéutico, capa de comprimido comprendiendo ingrediente activo telmisartan, un agente basico y sorbitol, proceso de preparacion y aplicaciones,
GT200600097A (es) Formas farmaceuticas con propiedades farmacocineticas mejoradas
TW200833378A (en) Disinfecting tablet
DOP2005000248A (es) Agentes citotoxicos que comprendentaxanos nuevos.
CL2008001678A1 (es) Forma de dosificación farmacéutica de liberacion prolongada en forma de comprimido, que consiste de nevirapina anhidra, hipromelosa, lactosa monohidrato y estearato de magnesio; y su procedimiento de preparación, util para el tratamiento de una infeccion por vih-1.
AR062925A1 (es) Metodo para fabricar tabletas que contienen agentes farmacologicamente activos
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
UY29777A1 (es) Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos del sueno en pacientes con depresión.
PL1845957T3 (pl) Sposób uzyskiwania ekstraktu leku zawierającego hydroksystylben
EP1961413A4 (en) FAST CRUMPING ORAL TABLET
CA121739S (en) Stamp
BRPI0610780A2 (pt) formulação farmacéutica em tablete desintegrante, e, métodos para tratar um paciente em necessidade de tratamento com olanzapina, e para produzir a formulação farmacêutica em tablete
MX2009004113A (es) Composicion que comprende un antagonista del receptor de neuroquinina-1 y un inhibidor selectivo de la recaptacion de serotonina para el tratamiento de tinnitus y perdida auditiva.

Legal Events

Date Code Title Description
FB Suspension of granting procedure